Antitissue transglutaminase antibodies in acute coronary syndrome: an alert signal of myocardial tissue lesion?

作者: M. Di Tola , F. Barillà , M. Trappolini , H. F. Palumbo , C. Gaudio

DOI: 10.1111/J.1365-2796.2007.01881.X

关键词:

摘要: . Background and aim.  Antitransglutaminase, previously considered identical to antiendomysial in coeliac sprue (CS), have been reported end-stage heart failure. To clarify the above-mentioned data, we evaluated these antibodies a cohort of cardiological patients with respect troponin I, creatine kinase (CK), MB fraction (CK-MB mass) myoglobin. Methods.  Forty-one acute coronary syndrome (ACS), 39 dilated cardiomyopathy (DCM), 45 CS 58 blood donors (BDs) were evaluated. Antitransglutaminase tested serum being studied. Results.  High-positive antitransglutaminase values found CS, whilst low-positive also ACS DCM. In at second ACS, antibody levels higher than those first cardiac event. infarct Q, non-Q, which unstable angina. A correlation between CK, CK-MB mass myoglobin was found. Finally, rose reach peak 30 days from event, whereas after further 150 days, approached BDs. Antiendomysial detectable only CS. Conclusions.  Data highlight that can occur patients, are related severity/extent myocardial tissue lesion. This feature suggests loss specificity for CS. Furthermore, possibility employing long-term follow-up could become an object interesting discussion.

参考文章(19)
David, C. Sane, Roles of transglutaminases in cardiac and vascular diseases Frontiers in Bioscience. ,vol. 12, pp. 2530- 2545 ,(2007) , 10.2741/2253
Mauro Piacentini, Alessandra Amendola, Fabiola Ciccosanti, Laura Falasca, Maria Grazia Farrace, Pier Giorgio Mastroberardino, Roberta Nardacci, Serafina Oliverio, Lucia Piredda, Carlo Rodolfo, Francesco Autuori, Type 2 transglutaminase and cell death. Progress in Experimental Tumor Research. ,vol. 38, pp. 58- 74 ,(2005) , 10.1159/000084233
Jiří Stulík, Lenka Hernychová, Stanislava Porkertová, Oldřich Pozler, Ludmila Tučková, Daniel Sánchez, Jan Bureš, Identification of new celiac disease autoantigens using proteomic analysis PROTEOMICS. ,vol. 3, pp. 951- 956 ,(2003) , 10.1002/PMIC.200300370
Holm H. Uhlig, Juliane Lichtenfeld, Awad A. Osman, Thomas Richter, Thomas Mothes, Evidence for existence of coeliac disease autoantigens apart from tissue transglutaminase. European Journal of Gastroenterology & Hepatology. ,vol. 12, pp. 1017- 1020 ,(2000) , 10.1097/00042737-200012090-00009
H. BORNER, A. A. OSMAN, TH. MEERGANS, T. WEISKE, TH. MOTHES, Isolation of antigens recognized by coeliac disease autoantibodies and their use in enzyme immunoassay of endomysium and reticulin antibody-positive human sera Clinical and Experimental Immunology. ,vol. 106, pp. 344- 350 ,(1996) , 10.1046/J.1365-2249.1996.D01-850.X
Maddalena Peracchi, Maria Teresa Bardella, Daniele Prati, Massimo Longhi, Dario Conte, Maurizio Gasparin, Cristina Trovato, Cristina Tarantino, Tissue transglutaminase antibodies in patients with end-stage heart failure. The American Journal of Gastroenterology. ,vol. 97, pp. 2850- 2854 ,(2002) , 10.1016/S0002-9270(02)05450-3
Ricardo Schmit T De Bem, Shirley Ramos Da Ro Sa Utiyama, Renato Mitsunori Nisihara, Jerônimo Antônio fortunato, josuÉ Augusto Tondo, Eliane Ribeiro Carmes, Raquel Almada E. Souza, Julio CÉsar Pisani, Heda Maria Barska Dos Santos Amarante, Celiac Disease Prevalence in Brazilian Dilated Cardiomyopathy Patients Digestive Diseases and Sciences. ,vol. 51, pp. 1016- 1019 ,(2006) , 10.1007/S10620-006-9337-4